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Abstract: Hypertension is one of the most prevalent diseases and is often called the “silent killer” 
because there are usually no early symptoms. Hypertension is also associated with multiple 
morbidities, including chronic kidney disease and cardiovascular disease. Early detection and 
intervention are therefore important. The current routine method for diagnosing hypertension is 
done using a sphygmomanometer, which can only provide intermittent blood pressure readings and 
can be confounded by various factors, such as white coat hypertension, time of day, exercise, or stress. 
Consequently, there is an increasing need for a non-invasive, cuff-less, and continuous blood pressure 
monitoring device. Multi-site photoplethysmography (PPG) is a promising new technology that can 
measure a range of features of the pulse, including the pulse transit time of the arterial pulse wave, 
which can be used to continuously estimate arterial blood pressure. This is achieved by detecting 
the pulse wave at one body site location and measuring the time it takes for it to reach a second, 
distal location. The purpose of this review is to analyze the current research in multi-site PPG for 
blood pressure assessment and provide recommendations to guide future research. In a systematic 
search of the literature from January 2010 to January 2019, we found 13 papers that proposed novel 
methods using various two-channel PPG systems and signal processing techniques to acquire blood 
pressure using multi-site PPG that offered promising results. However, we also found a general lack 
of validation in terms of sample size and diversity of populations. 
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1. Introduction 
Hypertension (HTN), defned as a blood pressure (BP) above 140/90 mmHg on two or more 
occasions, is one of the most prevalent diseases, affecting over 1 billion people world-wide [1]. 
The European Society of Cardiology and the European Society of Hypertension estimates that by 2025, 
the number of affected people will be 1.5 billion [1]. HTN is often called the “silent killer” because 
there are usually no symptoms, but it is associated with chronic kidney disease, cardiovascular disease, 
and death [2]. In addition, hypertension in pregnancy is associated with preterm birth, still birth, 
intrauterine growth restrictions, neonatal thrombocytopenia, and bronchopulmonary dysplasia [3]. 
Therefore, early detection and intervention are critical. 
1.1. The Need for a Non-Invasive Continuous Blood Pressure Monitor 
The current industry gold standards of blood pressure assessment are the manual 
sphygmomanometer (BP cuff) and invasive blood pressure (IBP) measurements [4]. The invasive 
arterial line is currently only used in high-risk surgical patients or critically ill patients who require 
instantaneous BP measurements [5]. As expected, it is not used outside of the inpatient setting 
because of the risks associated with arterial cannulation, such as temporary occlusion, infection, or 
vascular damage [5]. The cuff-based sphygmomanometer is the most frequently used method of BP 
measurement in hospitals, in family practice offices, and at home. While the manual auscultatory 
method is the gold standard, the automatic BP cuff is also often used because of its convenience. 
The automatic BP cuff depends on the measurement of oscillometric changes in pressure during 
cuff defation [6]. However, in both BP cuff methods, BP can only be measured intermittently and 
can be affected by factors such as white coat HTN, masked HTN, caffeine, exercise, or stress [7]. 
These measurements also provide no additional information on the cardiovascular status of the 
patient. Intermittent measurements using a sphygmomanometer are therefore not an ideal method for 
monitoring the long-term management of HTN [8]. Additionally, ambulatory home BP self-monitoring 
has been shown to be able to detect HTN disorders earlier than office measurements [9]. There are 
currently 24-h ambulatory BP monitoring (24hABPM) devices that can measure BP intermittently 
over the span of a day that have been shown to improve accuracy and predict cardiovascular risk. 
While the 24hABPM is superior to the BP cuff methods in that it can track BP trends throughout the 
day, it is not entirely non-invasive. The patient has to carry the device with an attached cuff that is set 
to infate once every 15–20 min [10], which can be distracting and uncomfortable at the least, and could 
even cause microvascular damage (bruising) and pain in some patients [11]. In addition, the use of 
this device is costly [10]. As the prevalence of HTN increases, there is a growing need for a wearable, 
cuff-less, and non-invasive BP monitor that is cost-effective and can continuously monitor a patient’s 
blood pressure throughout day-to-day activities. 
1.2. Photoplethysmography to Estimate BP 
Photoplethysmography (PPG) is a technology that illuminates perfused tissue and then measures 
light that is either refected or transmitted back to a photosensor, giving a measurement of blood 
volume [12]. Traditionally, PPG has been used to measure oxygen saturation in the fnger, widely 
known as the pulse oximetry technique; however, PPG has also been shown to be able to detect 
changes in blood volume and the pulse wave of blood fow during systole [12]. The ability of PPG to 
detect the arterial pulse wave is a promising method for obtaining continuous BP measurements in 
a small and convenient wearable device. There have been increasing numbers of studies exploring 
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this potential over the past decade, investigating using PPG in combination with electrocardiography 
(ECG), ballistocardiography (BCG), phonocardiography (PCG), impedance plethysmography (IPG), 
and tonometry [13]. Notably, many papers use a combination of ECG and PPG to estimate BP, with 
ECG used to determine the start of systole and PPG used in the periphery to determine the time taken 
for the pulse wave to reach a certain distance. This measured time is known as the pulse arrival time 
(PAT), which is defned as the time it takes the pulse wave to travel from the heart to the periphery and 
is proportional to BP [14]. 
1.3. Vagueness of Terminology 
One of the difficulties of understanding research in PPG is the interchangeability of several key 
terms. This inconsistency in terminology can create confusion between research questions, protocol 
development, and fndings, so we wanted to address it early in the review. In many publications, PAT 
is used interchangeably with pulse transit time (PTT). These two are not the same; the key difference is 
when this time interval starts. The beginning of the PAT is measured from the R wave of the ECG; 
therefore, it includes the pre-ejection period (PEP), which is the time it takes for blood to leave the 
heart after the heart’s electrical impulse [15]. PTT on the other hand is defned as the time it takes for 
a pulse wave to travel a known distance and does not include the PEP. It is inversely proportional 
to pulse wave velocity (PWV), which is the speed of the pulse wave along the arterial vessel [16]. 
Another point of confusion is that multi-site PPG is often used to describe a system that uses two PPG 
probes, but it can extend up to multiple channels [17]. In this review, we will consider dual PPG (two 
probes) as the key type of multi-site PPG in blood pressure assessment. 
1.4. Multi-Site PPG 
One of the limitations of the ECG–PPG method is that the PAT includes the PEP. This artifact 
reduces the accuracy of the BP estimation [15]. One of the ways to account for this is to measure 
the pulse wave at a proximal location rather than to measure the electrical impulse of the heart. 
Several studies have examined multi-site dual PPG based on just two PPG sensors, in which the ECG 
is replaced by a second PPG, thereby removing the confounding PEP component [16]. The resulting 
time interval from when the pulse wave is detected by the frst PPG to when it is detected by the 
distal PPG is known as the pulse transit time (PTT), which is more accurately correlated to BP than 
the PAT [15]. The two PPG probes can be relatively proximal–distal, that is, not directly connected 
in the vascular tree (e.g., forehead to toe) [18], or they can be proximal–distal along the same artery 
(e.g., proximal brachial to distal brachial artery), as shown in Figure 1 [16]. Figure 2 shows an example 
of multi-site PPG being used to calculate PTT such that it is signifcantly correlated (p < 0.001) with 
systolic BP (SBP). Note that each data point in Figure 2 represents a subject for either PTT (ear to toe) 
or (fnger to toe), where a total of 116 subjects were used in the analysis. 
We performed a literature search for all research from January 2010 to January 2019 regarding 
multi-site PPG as a method for BP measurement. The purpose of this review is to gain an understanding 
of multi-site PPG as one of the potential technologies amongst several (Figure 1) to assess the current 
trends in the literature and to guide future research. We found that the amount of research in this feld 
is limited. The majority of the studies on multi-site PPG had small sample sizes (e.g., typically 5–20 
healthy subjects), with no hypertensive subjects or subjects with co-morbidities. Therefore, it appears 
that there is a lack of validation for this technology in clinical groups. 
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Figure 1. A visualization of the methods multi-site photoplethysmography (PPG) to measure the 
pulse transit time (PTT). Multisite PPG can make use of twos PPG probes, one proximal and one 
distal, to measure the time it takes for the pulse wave to travel a distance. (A,B) Two-location dual 
PPG/iPPG systems. (C) iPPG system. (D) Single artery dual PPG system. (E) Multiple wavelengths 
system. ECG—electrocardiography, IPG—impedance plethysmography, 
BCG—ballistocardiography, PCG—phonocardiography, PPG—photoplethysmography, 
iPPG—image-based PPG, and MWPPG—multi-wavelength PPG. 
 
Figure 2. Dual probe multi-site PPG-derived pulse transit time (PTT) correlation with systolic blood 
pressure (SBP). The data used in this figure were adapted from Allen and Murray [19]. 
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2. Methods 
We conducted a thorough lite ature search using PubMed fo  articles exploring the use of multi-site 
PPG for BP measuremen  from 1/1/2010 to 1/1/2019. PubMed was used because it gave access  
journal articles as well as conference p ocee ings. W  decided to limit our search to the most recent 
dec de, i.e., January 2010 to January 2019, because we were i terested in the tren  of the development 
of this te hnology in the recent decadal time frame. Note that the typical time frame is the mo t 
recent d cade [20–22]. We us d the foll wing search terms, combined with “OR”, using PubMed’s 
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advanced search feature: ppg blood pressure determination, ppg blood pressure estimation, ppg 
hypertension estimation, ppg non-invasive blood pressure, ppg cuffless blood pressure, ppg cuff-less 
blood pressure, photoplethysmographic blood pressure determination, photoplethysmographic blood 
pressure estimation, photoplethysmographic hypertension determination, photoplethysmographic 
hypertension estimation, non-invasive hypertension classifcation, non invasive blood pressure 
monitoring, pulse transit time blood pressure estimation, multi-ppg blood pressure, multi-site ppg 
blood pressure, and multi-photoplethysmographic blood pressure. Our initial searches returned a 
signifcant number of studies regarding arterial stiffness and vascular disease; we therefore added 
the search term “NOT arterial stiffness.” We are aware of the relatedness of vascular disease with 
hypertension [23]; however, including analysis of vascular disease via PPG would mean including 
many studies unrelated to BP. Therefore, we decided to limit the scope of our study to multi-site PPG for 
the analysis of BP in the hope that we could make more meaningful and BP focused recommendations. 
We included any publication that examined multi-site PPG as a method for BP measurement. 
Our exclusion criteria included animal studies, review articles, articles that are not accessible in the 
English language (see the Appendix A), articles in which PPG was not used to estimate blood pressure, 
and articles that validated a trademarked PPG device with no discussion of the PPG technology or 
waveform itself. From January 2010 to January 2019, our search found 13 papers that ft the inclusion 
criteria (Figure 3). 
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3. Results 
Our PubMed search found 13 publications that studied multi-site PPG technology; all but one 
paper looked at using two measurement sites with a two-probe system [24]. The two probes are used 
to measure PTT (or its inverse PWV), which is correlated with BP. From January 2010 to January 
2019, multi-site PPG publications followed a growing trend (Figure 4). In our analysis, we 
determined the sample sizes of each paper, the inclusion of any subjects with HTN or co-morbidities, 
and the method used as the gold standard to collect the reference BP measurements for comparison. 
Of these papers, only three had a sample size of more than 30 subjects: one each in 2011 [18], 2017 
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3. Results 
Our PubMed search found 13 publications that studied multi-site PPG technology; all but one 
paper looked at using two measurement sites with a two-probe system [24]. The two probes are used 
to measure PTT (or its inverse PWV), which is correlated with BP. From January 2010 to January 2019, 
multi-site PPG publications followed a growing trend (Figure 4). In our analysis, we determined the 
sample sizes of each paper, the inclusion of any subjects with HTN or co-morbidities, and the method 
used as the gold standard to collect the reference BP measurements for comparison. Of these papers, 
only three had a sample size of more than 30 subjects: one each in 2011 [18], 2017 [16], and 2018 [25]. 
In addition, most of the papers either used healthy subjects with no HTN, co-morbidities, or pregnant 
women, or used health statuses that were undisclosed. One paper [26] compared hypertensive (N = 10) 
and normotensive (N = 10) subjects, as well as patients undergoing coronary angiography (N = 4). 
Another publication collected data from patients undergoing general anesthesia (N = 35) [18]. 
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Several of the papers did not use the gold standard BP measurement methods (inter-arterial 
line or sphygmomanometer) for their comparisons. Instead, they used less validated methods for 
obtaining the reference BP, such as devices that employ the volume-clamp method, other PPG methods, 
applanation tonometry, or no reported reference at all. The volume-clamp method, also known as 
fnger arterial non-invasive BP, uses a PPG probe to measure the volume of blood in the fngertip 
and a beat-to-beat adjusting cuff that exerts pressure to maintain the volume detected by the PPG. 
In theory, this cuff pressure is equal to the systolic BP. Some publications have verifed its validity in 
different applications [27], but others have shown its measurements to be different from invasive BP 
measurements [28]. Since the automatic sphygmomanometer is widely used in the clinical setting, 
for our study, we considered an automatic BP cuff as an appropriate gold standard [6]. Only eight 
publications used an appropriate gold standard for assessing the reference BP, where two used invasive 
arterial blood pressure and six used a sphygmomanometer (manual or automatic) (Figure 5) 
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3.2. I duced Changes in BP 
Many studies included a protocol that induced changes in BP during measurement, as shown 
in Figure 6. In addition to physical exercise, other experimental tasks were used to drive changes 
in the autonomic nervous system and thus alter BP as a response through the baroreceptors and 
vasoconstriction. Such techniques included anesthesia, the Valsalva maneuver, a tilt table, and 
J. Clin. Med. 2019, 8, 1827 7 of 14 
cold-pressor test. In other techniques, a brachial cuff was used to occlude the brachial artery, which 
causes a rise in blood pressure in the carotid artery where the measurements take place [29]. Using these 
techniques to induce changes in the blood pressure allowed the studies to show that the technology 
is sensitive and accurate over some range of BPs. However, the range of induced BP values is 
generally limited. 
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technology is sensitive and accurate over some range of BPs. However, the range of induced BP 
values is generally limited.  
 
Figure 6. A representation of the methods used in the studies to provoke changes in blood pressure 
during validation of the multi-site PPG technique. Exercise = stationary calf raises, hand grip 
exercise, or physical activity immediately before measurement; anesthesia = general anesthesia; 
cuff-induced hypertension = BP cuff used to occlude the brachial artery to artificially raise the BP in 
the carotid; Valsalva maneuver = exhaling against a closed glottis; N/R = not reported. 
3.3. Accuracy of BP Estimation 
The accuracy of BP estimations of each analyzed publication is summarized in Table 1. There 
were two methods used to determine the accuracy in comparison with the reference BP: mean 
absolute difference and Pearson’s correlation coefficient (r). Three publications did not analyze their 
method in comparison to a reference BP. One publication expressed reliability in their 
measurements by showing that beat-to-beat variations of the measured PWV was less than 15% [29]. 
Another analyzed the correlation of PTT measurements from the wrist to different fingers (index, 
middle, ring, little) and found an absolute correlation value of 0.95 [30]. The third publication 
compared the PTT using their proposed method with PTT using the ECG–PPG method giving  r 
value of 0.86 ± 0.06 [31]. Only one study found that PTT was poorly correlated with BP [32]. 
Figure 6. A representation of the methods used in the studies to provoke changes in blood pres ure 
during validation of the multi-si e PPG technique. Ex rcise = stationary calf aises, hand grip exercise, 
or phy ical activity immediately before measurem nt; anesthesia = general anesth sia; cuff-induced 
hypertension = BP cuff used to occlude the bra hial art ry to artifcially raise the BP in the carotid; 
Valsalva maneuver = exhaling against a closed glottis; N/R = no  reported. 
3.3. Accuracy of BP Estimation 
The accuracy of BP estimations of each analyzed publication is summarized in Table 1. There were 
two methods used to determine the accuracy in comparison with the reference BP: mean absolute 
difference and Pearson’s correlation coefficient (r). Three publications did not analyze their method in 
comparison to a reference BP. One publication expressed reliability in their measurements by showing 
that beat-to-beat variations of the measured PWV was less than 15% [29]. Another analyzed the 
correlation of PTT measurements from the wrist to different fngers (index, middle, ring, little) and 
found an absolute correlation value of 0.95 [30]. The third publication compared the PTT using their 
proposed method with PTT using the ECG–PPG method giving r value of 0.86 ± 0.06 [31]. Only one 
study found that PTT was poorly correlated with BP [32]. 
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Table 1. Summary of fndings of all papers included in this review. 
Year Authors # Subjects 
Age Range of 
Subjects (Years) Gold Standard Parameters Measured 
Mean BP 
Absolute 
Difference 
Absolute of Value of 
Correlation Coefficient between 
Estimated BP (or PTT Feature) 
and Referenced BP 
2018 Liu et al. [26] 
N1 = 10 
N2 = 10 
N3 = 4 
N/R 
N/R 
Finometer 
IBP 
PTT (ECG, ICG, FingerPPG) 
PTT (MW FingerPPG) 
1.86 mmHg MAP 
2.72 mmHg MAP 
N/R 
N/R 
2018 Wang et al. [25] N1 = 30 20–27 BP Cuff PTT (WristPPG to ArmPPG with MA) N/R 
r = 0.75 SBP 
r = 0.78 DBP 
2018 Viejo et al. [24] N1 = 15 20–38 BP Cuff PTT (2 cheeksPPG, foreheadPPG) N/R r = 0.85 BP 
2017 Nabeel et al. [16] N1 = 35 23–32 BP Cuff 
PTT (CarotidPPG to CarotidPPG) 
PTT (CarotidPPG to FingerPPG) 
PTT (ECG to CarotidPPG) 
N/R 
r = 0.74 SBP 
r = 0.77 DBP 
r = 0.78 MAP 
2017 Nabeel et al. [29] N1 = 5 24–30 Tonometry PTT (CarotidPPG to CarotidPPG) N/R N/R 
2017 Beckmann et al. [30] N1 = 5 25–36 N/R 
PTT (WristPPG to Index FingerPPG) 
PTT (WristPPG to Middle FingerPPG) 
PTT (WristPPG to Ring FingerPPG) 
PTT (WristPPG to Little FingerPPG) 
N/R N/R 
2017 Zhang et al. [33] N1 = 29 20–30 BP Cuff 
PTT (FacePPG to FingerPPG) 
PTT (TemplePPG to WristPPG) 
N/R r > 0.6 SBP in 75.9% subjects 
2016 Nabeel et al. [34] N1 = 17 21–34 BP Cuff PTT (CarotidPPG to CarotidPPG) N/R 
r = 0.68 SBP 
r = 0.71 DBP 
r = 0.72 MAP 
2016 Liu et al. [35] N1 = 10 22–26 Finometer 
PTT (ECG to FingerPPG) 
PTT (MW FingerPPG) 
N/R r = 0.76 SBP 
2015 Nabeel et al. [36] N1 = 13 22–31 BP Cuff PTT (CarotidPPG to CarotidPPG) N/R 
r = 0.5 SBP 
r = 0.66 SBP 
r = 0.63 MAP 
2015 Liu et al. [31] N1 = 12 24–35 ECG–PPG PAT PTT (TemplePPG to Index FingerPPG) N/R N/R 
2011 Chen et al. [18] N4 = 35 17–21 and 58–62 IBP PTT (EarPPG to ToePPG) 
2.16 mmHg SBP 
1.49 mmHg DBP N/R 
2010 Proenca et al. [32] N1 = 20 20–37 Finometer 
PTT (ECG, ICG, unspecifed PPG) 
PTT (EarPPG to FingerPPG) 
N/R r = 0.22 SBP 
N1 = normotensive subjects, N2 = hypertensive subjects, N3 = patients undergoing coronary angiography, N4 = patients under general anesthesia, r = Pearson’s correlation coefficient, 
Finometer = fnger blood pressure, IBP = invasive BP, MW = multi-wavelength, MA = motion artifact, ECG = electrocardiogram, ICG = impedance cardiography, PTT = pulse transit time, 
N/R = not reported, SBP = systolic BP, DBP = diastolic BP, MAP = mean arterial pressure, FingerPPG = PPG collected from a fnger. 
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4. Discussion 
Of the 13 publications, only one study, Chen et al. [32], found two-channel PTT (earlobe and fnger, 
N = 20) to be poorly correlated with BP. This poor correlation is suggested to be due to the fact that the 
devices used had a low accuracy and sensitivity in comparison to the small changes in PTT associated 
with the changes in BP. In their study, the PTT varied with a massive uncertainty of ±11 ms, which was 
associated with a variation in the BP readings of approximately ±20 mmHg (r = 0.22). 
One of the studies, Beckmann et al. [30], only looked at the reproducibility of the measurements 
using a wrist to fnger PPG (N = 5). This study had neither a gold standard for measuring the reference 
blood pressure, nor did they have any reports of accuracy of their measurements. However, they were 
able to show an excellent agreement within multiple measurements using different fngers (r = 0.95). 
Another study, Viejo et al. [24] used multi-site PPG with more than two locations, using raw video 
analysis of multiple locations of the face (N = 15). Using machine learning, they were able to create an 
algorithm to predict the SBP with an accuracy of r = 0.85, which is the most accurate SBP prediction 
amongst the studies included here. 
Yet another study, Chen et al. [18], used ear–toe dual PPG to measure PWV to estimate BP. 
The advantage of this study is that it was conducted on patients undergoing general anesthesia. 
In addition, this is the only study included in our analysis that examined patients of different age 
ranges (17–21 and 58–62 years). However, a limitation of their experiment is the small sample size. 
Although they had more than 30 subjects (N = 35), they separated their experimental validation into 
two separate experiments: validation of PWV (N = 9) and validation of BP measurement (N = 26). 
Furthermore, they had two different age groups; therefore, it would be ideal to have a larger sample 
size. Another limitation of the study is that there is insufficient information about the subjects. Chen et 
al. notes that data acquisition was done in the operating room before, during, and after anesthesia. 
However, how the nature of the surgeries, health of the subjects, and the use of any medication could 
affect the BP is unknown. 
4.1. Wearable PPG-Based Devices 
One of the main motivators for studying multi-site PPG is its potential for incorporation into a 
wearable device to continuously monitor BP in an ambulatory setting. This would be designed to 
allow for the early detection of HTN and provide an accurate and complete profle of BP control in 
hypertensive patients. Based on the research found, there seem to be two major barriers to creating a 
wearable device. First, the device must be compact enough to be convenient to wear on a daily basis, 
and second, PPG measurements are usually highly sensitive to body movements, where the signal 
collected contains motion artifacts that can decrease the accuracy of the BP estimation. 
4.2. Compact Design 
A second study, Liu et al. [31], proposed the use of the front and back cameras on a smartphone to 
measure PTT. The device used in the study had one camera surrounded by a ring of light-emitting 
diode (LED) lights on one side and a standalone camera on the other side. The side with the LED lights 
was pressed against the temple while the index fnger of the right hand was pressed against the second 
camera, in a position similar to when one is talking on a phone. The camera for the index fnger was 
illuminated using ambient light from both daylight and fuorescent lighting. One of the limitations 
of this study was that they only compared this multi-site PTT result with an ECG–PPG-derived PTT. 
They did not compare the PTT with any measurements of BP. 
One of the earliest published multi-site PPG studies, McCombie et al. [37], demonstrated how 
multiple PPG probes can be attached to a single artery on the hand in the form of an extended glove. 
Although the PTT delay is quite short, the current microcontroller technology can readily measure 
pulse timings with a microsecond accuracy and thus can be used to estimate BP changes. 
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Similarly, Nabeel et al. [16,29,34,36], explored ways to collect multi-site PPG using only one probe 
on one part of the body. They used a single device with one infrared (IR) LED and two PPG probes that 
were a fxed distance apart to measure the PTT along a single artery. This solves several issues. First, it 
eliminates the inaccuracies from estimating the distance between the two PPG probes. Second, when 
two probes are located on different body parts, there is an inaccuracy associated with the multiple 
branch points between points A and B and the multiple refections of the wave. Lastly, only one device 
is needed. Three of the four studies used a sphygmomanometer as the gold standard, while one used 
tonometry [29]. Of the four studies, only one had a sample size of 35 normotensive subjects [16]. 
Another two studies, Liu et al. [26,35], explored the use of a single PPG device with 
multi-wavelength probes for measuring PTT. Signals with shorter wavelengths were dispersed 
superfcially and represented capillaries, while longer wavelengths penetrated deeper and represented 
arterioles. The time difference between IR-PPG (“arterioles”) and blue-PPG (“capillaries”) was used 
to calculate PTT. This PTT was then compared with the ECG–PPG PTT. The BP was simultaneously 
compared with a reference BP. The beneft of this method is that it allows for a small device that can be 
worn in a single location; one of these studies suggested implementation into a smart watch, ring, or 
earbud [26]. In addition, this study had four subjects that were undergoing a coronary angiography. 
A limitation of these studies was that they used the fnger clamp method as the gold standard. 
4.3. Imaging PPG 
More recently, it has been demonstrated that the optical pulse perfusion in the human skin can 
be measured with a camera [38]. This technique is now known as “imaging PPG” (iPPG) or “video 
plethysmography.” By processing the separate color channels in the camera image, the separate color 
channels can be combined using blind source separation methods to reconstruct the pulse waveform. 
Since a camera can measure the pulse at multiple points on the body simultaneously, researchers have 
developed a variety of methods using iPPG to estimate blood pressure. 
Hybrid techniques have also been developed. Zhang et al. [33] proposed a possible smart watch 
application using contact PPG and iPPG. The smart watch would contain a contact PPG probe for 
the wrist and a camera to analyze the face for an iPPG when the watch is raised towards head level. 
The iPPG would then use computer software to analyze the changes in light on the skin surface to 
detect the pulse wave. However, the iPPG was collected under a single fuorescent lamp only, and the 
contact PPG used in the experiment was a normal fnger PPG. It is unclear how the system would 
perform under the varying spectrum of possible lighting scenarios in day-to-day living. Still, this study 
provides a proof of concept for a nonintrusive method of obtaining two PPG signals to calculate BP. 
The iPPG was frst demonstrated on a smart phone by Poh et al. [39]. Fletcher et al. was one of the frst 
to investigate the effect of different ambient lighting on iPPG using an Android phone [40]. A recent 
iPPG study [41], with the use of a smartphone camera, showed promising results toward measuring 
blood pressure; however, the data were collected only from normotensive subjects. 
4.4. Mitigating Motion Artifacts 
Only one study, Wang et al. [25], addressed the issue of motion artifacts, a key challenge to reliable 
clinical measurements with the PPG. Their study used two PPG sensors (one on the arm, one on the 
wrist) and an accelerometer at the wrist. The accelerometer was used to identify and remove motion 
artifacts from the PPG signal. The study was able to show reliable BP measurements while subjects 
were walking with a normal arm swing. While this study was performed under controlled laboratory 
settings that did not fully encompass the range of movement in day-to-day living, it did show that 
motion artifacts can often be accounted for and its effects mitigated via signal processing, but that this 
is a key area of development needed for ambulatory PPG-based BP assessments. 
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5. Recommendations 
As mentioned in the introduction, a vast majority of the publications use the term “multi-site PPG” 
to describe a dual PPG system. In our literature search, there was only one study that used more than 
two PPGs in the analysis of BP. This study used PPG analysis of three facial regions in combination 
with machine learning in order to develop an algorithm for BP prediction [24]. In addition, PTT and 
PAT are routinely used interchangeably. Our recommendation is: 
(1) to apply all recommendations in Elgendi [12] but in multiple PPG confgurations, 
(2) to compare the performance features extracted from signal PPG signals and multiple PPG 
signals for assessing BP, 
(3) to optimize the locations of measurement for extracting PTT that are correlated with BP, 
(4) to include more unhealthy subjects with co-morbidities, 
(5) to include subjects from different age ranges, 
(6) to explore different noisy environments, and 
(7) to investigate the integration of multiple PPG sensors (contact and non-contact) in intelligent 
clothing or wearable devices. 
A thorough literature search using PubMed revealed only 13 publications from January 2010 to 
January 2019 regarding the use of multi-site PPG for BP estimation. The research suggests that PPG 
simultaneously from a range of body sites is a promising approach for the continuous tracking of BP. 
The current research landscape is lacking given the increasing need for a technology to continuously 
and non-invasively monitor BP. The main shortcoming is that a majority of research studies do not 
have large enough sample sizes, nor do they include participants with co-morbidities. That being said, 
a surprising number of studies used a method of BP provocation, showing that their approaches are 
sensitive to changes in BP. There were also many different approaches to creating a device that would 
be convenient to wear on a daily basis. The direction of future research should be toward validating 
the proposed technologies using larger sample sizes and broader populations. 
6. Conclusions 
A systematic review of multi-site PPG-based blood pressure measurement studies from January 
2010 to January 2019 was conducted, revealing that there were many studies with promising PPG 
technologies, but were not mature enough to make a powerful and statistically signifcant contribution 
toward the reliable non-invasive measurement of arterial blood pressure. This review creates the 
necessary motivation for research groups around the globe to intensify their efforts toward the 
creation of a much needed disruptive technology offering non-invasive, cuff-less, continuous, and 
calibration-free measurement of blood pressure. 
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Appendix A Appendix 
The titles (translated into English) of articles that are not accessible in English language: 
(Clinical effect of lower tidal volume combined with lung recruitment maneuver on ARDS for 
post-operative esophageal carcinoma surgery patients). 
(Comparison of early retinal microvascular changes and microalbuminuria as indicators for 
increased cardiovascular risk). 
J. Clin. Med. 2019, 8, 1827 12 of 14 
(Pilot study: Wrist digital sphygmomanometers as an alternative for non-invasive blood pressure 
measurement in pediatric population). 
(Ventilation strategies for chronic obstructive pulmonary disease). 
(Results of using the dosing Valsalva–Weber test to determine autonomic disorders in patients 
with vasovagal syncope). 
(Monitoring oxygen consumption in energy metabolism in pediatric anesthesia: clinical utility). 
(Pulmonary hypertension: a rare cause of unexplained dyspnea). 
(Minimally invasive treatment of Dupuytren’s contracture using Pi needle percutaneous 
multi-segmental fasciotomy). 
(Analysis of thyroid homeostasis disorders in patients with severe traumatic brain injury). 
(Central sleep apnea (Ondine’s curse syndrome) in medullary infarction). 
(The coronary patient six months after cardiac rehabilitation: rehabilitation evaluation research 
(RER study)). 
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